![Jon Saxe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jon Saxe
Vorsitzender bei
VISTAGEN THERAPEUTICS, INC.
Vermögen: 1 171 $ am 31.05.2026
Profil
Jon Sheldon Saxe currently works at Vistagen Therapeutics, Inc., as Independent Chairman from 2026, Vytacera Pharma, Inc., as Chairman, Epalex Corp., as Chairman from 2017, and various other companies.
Mr. Saxe also formerly worked at Synergen, Inc., as President, Chief Executive Officer & Director from 1989 to 1993, SciClone Pharmaceuticals LLC, as Chairman from 2009 to 2017, POINT Biomedical Corp., as Chairman, and various other companies.
Mr. Saxe received his undergraduate degree from Carnegie Mellon University, graduate degree from George Washington University Law School, and graduate degree from New York University School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.09.2025 | 1.858 ( 0 % ) | 1 171 $ | 31.05.2026 |
Aktive Positionen von Jon Saxe
| Unternehmen | Position | Beginn |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Vorsitzender | 01.06.2000 |
| CANCER PREVENTION PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 23.07.2015 |
| K2X TECHNOLOGY & LIFE SCIENCE, INC. | Direktor/Vorstandsmitglied | 08.01.2021 |
Vytacera Pharma, Inc. | Vorsitzender | - |
Trellis Bioscience, Inc.
 Trellis Bioscience, Inc. BiotechnologyHealth Technology Develops treatments for infectious diseases, cancer and oncology indications | Direktor/Vorstandsmitglied | 01.06.2016 |
Achelios Therapeutics, Inc.
 Achelios Therapeutics, Inc. BiotechnologyHealth Technology Develops pharmaceutical products for the treatment of pain and inflammation by topically delivered medications | Direktor/Vorstandsmitglied | 01.11.2019 |
Aether, Inc. | Direktor/Vorstandsmitglied | 01.03.2020 |
Epalex Corp.
 Epalex Corp. Miscellaneous Commercial ServicesCommercial Services Develops drugs for novel treatments to improve the quality of life for people with migraine and epilepsy | Vorsitzender | 01.08.2017 |
Arcuo Medical, Inc.
 Arcuo Medical, Inc. Medical SpecialtiesHealth Technology Manufactures surgical and medical instruments | Direktor/Vorstandsmitglied | 25.06.2011 |
| ░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ehemalige bekannte Positionen von Jon Saxe
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Jon Saxe
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
42
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 42 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
InSite Vision, Inc.
 InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceutical products | Health Technology |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer and infectious diseases | Health Technology |
Synergen, Inc.
 Synergen, Inc. Electric UtilitiesUtilities Distributes electricity | Utilities |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Health Technology |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cell Pathways, Inc.
 Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat cancer | Health Technology |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets and sells prescription drugs | Health Technology |
Shionogi Pharma, Inc.
 Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
DURECT Corp.
 DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Kyto Technology & Life Science, Inc.
 Kyto Technology & Life Science, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary drugs for the treatment of cancer, arthritis and other autoimmune diseases | Health Technology |
Trellis Bioscience, Inc.
Trellis Bioscience, Inc. BiotechnologyHealth Technology Develops treatments for infectious diseases, cancer and oncology indications | Health Technology |
BaroFold, Inc.
 BaroFold, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes protein therapeutics | Health Technology |
POINT Biomedical Corp.
 POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology Develops biomedical-imaging products | Health Technology |
Arbor Vita Corp.
 Arbor Vita Corp. Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Commercial Services |
Iconix Biosciences, Inc.
 Iconix Biosciences, Inc. BiotechnologyHealth Technology Provides toxicogenomics products and services | Health Technology |
Entelos, Inc.
 Entelos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial partner that supports drug research and development teams | Commercial Services |
Excaliber Enterprises Ltd.
 Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Sells gift baskets via the Internet | Technology Services |
Cancer Prevention Pharmaceuticals, Inc.
 Cancer Prevention Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Achelios Therapeutics, Inc.
Achelios Therapeutics, Inc. BiotechnologyHealth Technology Develops pharmaceutical products for the treatment of pain and inflammation by topically delivered medications | Health Technology |
Institutional Venture Partners
 Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners invests in companies located in North America and Europe. The firm focuses on a broad range of sectors. It provides financing for growth stage capital requirements with the investment size of USD 15 - 75 millions. It also participates in follow on investments. | Finance |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Saxe Associates, Inc. | |
Amalyte Pharmaceuticals, Inc.
 Amalyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of immune and inflammatory diseases | Health Technology |
A-CUBE, Inc.
 A-CUBE, Inc. BiotechnologyHealth Technology Develops novel antibodies | Health Technology |
Altheos, Inc.
 Altheos, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
VistaGen, Inc. | |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
Arcuo Medical, Inc.
Arcuo Medical, Inc. Medical SpecialtiesHealth Technology Manufactures surgical and medical instruments | Health Technology |
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | Health Services |
Armetheon, Inc.
 Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cardiovascular focused late-clinical stage specialty pharmaceutical company | Health Technology |
George Washington University Law School
 George Washington University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vytacera Pharma, Inc. | |
Nuvox Pharma LLC
 Nuvox Pharma LLC Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Commercial Services |
Epalex Corp.
Epalex Corp. Miscellaneous Commercial ServicesCommercial Services Develops drugs for novel treatments to improve the quality of life for people with migraine and epilepsy | Commercial Services |
Sciele Pharmaceuticals, Inc. | |
Aether, Inc. |
